We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer.
$14.00 - $16.00
November 7, 2019
MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED,CITIGROUP GLOBAL MARKETS INC.
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for Galera Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277